Family history, compassion, a sense of moral obligation and an intense interest in the workings of the brain: these are the things that drove Caitlin McManus to intern at the Memory and Aging Program at Butler Hospital at the end of her senior year at Rhode Island College
The first infusion of an investigational drug that aims to delay or help to prevent the earliest memory loss due to Alzheimer’s disease took place in September at Butler Hospital in Providence, R.I., researchers announced.
Sam Slezak originally set out to become a trainer for professional athletes. Here’s how and why he became a project manager for a landmark national Alzheimer’s study instead.
The study seeks to identify new cognitive and neural biomarkers of preclinical Alzheimer’s disease, which would aid in earlier diagnosis and interventional treatment for the disease.
Caregiver to both her young husband and her father with dementia, now she’s supporting others in the caregiver journey.
The Memory and Aging Program at Butler Hospital is a world-wide leader in the fight against Alzheimer's. We are dedicated to developing breakthrough treatments for Alzheimer's disease through cutting-edge research into early detection and treatment.
Our research and future breakthroughs depend on the participation of people with normal memory who may be at risk for dementia and those who are already experiencing memory loss, as well as the support of committed community partners, supporters and volunteers.
Can healthy lifestyle changes help to protect memory and thinking in aging adults who are at risk? We’re looking for people ages 60 – 79 to participate in the U.S. POINTER study to find out.
READ MORE
After spending 25 years caring for Alzheimer’s patients Dr. Daniel Gibbs developed the disease himself. He’s now been living with it for at least 13 years, and he’s on a mission to spread an important message.
READ MORE